Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Inventory (2016 - 2018)

Historic Change in Inventory for Theravance Biopharma (TBPH) over the last 6 years, with Q4 2018 value amounting to $1.1 million.

  • Theravance Biopharma's Change in Inventory fell 7517.29% to $1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.6 million, marking a year-over-year decrease of 7768.8%. This contributed to the annual value of $1.6 million for FY2018, which is 7768.8% down from last year.
  • Per Theravance Biopharma's latest filing, its Change in Inventory stood at $1.1 million for Q4 2018, which was down 7517.29% from $201000.0 recorded in Q3 2018.
  • In the past 5 years, Theravance Biopharma's Change in Inventory registered a high of $4.3 million during Q4 2017, and its lowest value of -$912000.0 during Q4 2015.
  • Its 5-year average for Change in Inventory is $885500.0, with a median of $306000.0 in 2015.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 709615.38% in 2014, then tumbled by 54271.84% in 2015.
  • Over the past 5 years, Theravance Biopharma's Change in Inventory (Quarter) stood at $206000.0 in 2014, then tumbled by 542.72% to -$912000.0 in 2015, then skyrocketed by 247.37% to $1.3 million in 2016, then skyrocketed by 222.77% to $4.3 million in 2017, then crashed by 75.17% to $1.1 million in 2018.
  • Its last three reported values are $1.1 million in Q4 2018, $201000.0 for Q3 2018, and -$20000.0 during Q2 2018.